Group One Trading
AVDL

Group One Trading’s Avadel Pharmaceuticals AVDL Stock Holding History

Group One Trading’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-93,028
Closed -$2M – 7627
2025
Q4 		$2M Buy
93,028
+22,108
+31% +$429K ﹤0.01% 2282
2025
Q3 		$1.08M Buy
70,920
+49,164
+226% +$640K ﹤0.01% 2952
2025
Q2 		$193K Sell
21,756
-41,296
-65% -$363K ﹤0.01% 4382
2025
Q1 		$494K Sell
63,052
-10,643
-14% -$89.1K ﹤0.01% 3092
2024
Q4 		$775K Buy
+73,695
New +$895K ﹤0.01% 2791
2024
Q1 		– Sell
-62,799
Closed -$935K – 7031
2023
Q4 		$887K Buy
62,799
+56,616
+916% +$665K ﹤0.01% 2560
2023
Q3 		$63.7K Sell
6,183
-13,233
-68% -$177K ﹤0.01% 4871
2023
Q2 		$320K Sell
19,416
-93,551
-83% -$1.22M ﹤0.01% 3480
2023
Q1 		$1.03M Buy
112,967
+86,290
+323% +$709K ﹤0.01% 2109
2022
Q4 		$191K Buy
+26,677
New +$187K ﹤0.01% 3900
2022
Q2 		– Sell
-62,423
Closed -$256K – 7778
2022
Q1 		$426K Sell
62,423
-5,024
-7% -$34.5K ﹤0.01% 3996
2021
Q4 		$545K Buy
67,447
+559
+0.8% +$5.11K ﹤0.01% 4034
2021
Q3 		$656K Buy
+66,888
New +$527K ﹤0.01% 3892
2021
Q1 		– Sell
-21,113
Closed -$171K – 7555
2020
Q4 		$141K Sell
21,113
-25,330
-55% -$158K ﹤0.01% 4318
2020
Q3 		$234K Buy
+46,443
New +$338K ﹤0.01% 3528
2019
Q3 		– Sell
-6,311
Closed -$15.8K – 5128
2019
Q2 		$18K Buy
6,311
+4,662
+283% +$8.01K ﹤0.01% 4210
2019
Q1 		$2K Sell
1,649
-8,700
-84% -$19.7K ﹤0.01% 4569
2018
Q4 		$27K Sell
10,349
-15,133
-59% -$51.5K ﹤0.01% 3877
2018
Q3 		$112K Buy
25,482
+5,433
+27% +$29.3K ﹤0.01% 3449
2018
Q2 		$123K Sell
20,049
-12,666
-39% -$88.9K ﹤0.01% 3414
2018
Q1 		$238K Buy
32,715
+24,106
+280% +$212K ﹤0.01% 2647
2017
Q4 		$71K Buy
+8,609
New +$80.7K ﹤0.01% 3541
2017
Q1 		– Sell
-7,996
Closed -$83K – 4610
2016
Q4 		$83K Sell
7,996
-3,921
-33% -$43.1K ﹤0.01% 2953
2016
Q3 		$148K Buy
11,917
+4,114
+53% +$53.7K ﹤0.01% 2679
2016
Q2 		$84K Buy
+7,803
New +$83.2K ﹤0.01% 2977
2015
Q4 		– Sell
-19,197
Closed -$299K – 4718
2015
Q3 		$313K Buy
+19,197
New +$423K ﹤0.01% 2169
2015
Q2 		– Sell
-16,773
Closed -$301K – 4835
2015
Q1 		$302K Buy
16,773
+6,575
+64% +$103K ﹤0.01% 2026
2014
Q4 		$175K Buy
10,198
+1,667
+20% +$23.8K ﹤0.01% 2403
2014
Q3 		$122K Buy
8,531
+6,736
+375% +$96.8K ﹤0.01% 2817
2014
Q2 		$27K Sell
1,795
-11,345
-86% -$137K ﹤0.01% 3955
2014
Q1 		$176K Buy
13,140
+10,480
+394% +$112K ﹤0.01% 2552
2013
Q4 		$21K Buy
2,660
+2,000
+303% +$14.1K ﹤0.01% 4204
2013
Q3 		$4K Sell
660
-5,500
-89% -$33.8K ﹤0.01% 4805
2013
Q2 		$38K Buy
+6,160
New +$31.8K ﹤0.01% 3654

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Group One Trading's AVDL Position: Q1 2026 in Review

Group One Trading sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 93,028 shares — an estimated $2M sold.

Group One Trading first reported a position in AVDL in Q2 2013 and held it in 34 quarters. The position peaked at $2M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Group One Trading reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 93,028 Avadel Pharmaceuticals shares in Q1 2026, an estimated $2M.
  • Group One Trading first reported a position in Avadel Pharmaceuticals in Q2 2013 and held it in 34 quarters.
  • Group One Trading's Avadel Pharmaceuticals position peaked at $2M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.